Soft tissue sarcomas (STSs) represent a rare and heterogeneous group of solid tumours derived from mesenchymal progenitors and account for 1% of all adult malignancies. Although in the last decade anthracycline-based chemotherapy single agent or in combinations has been able to improve clinical benefits, prognosis is still poor and STSs represent an important unmet medical need. Continuous advances in cancer genetics and genomics have contributed to change management paradigms of STSs as it occurred for other solid tumours. Several treatments have been recently developed with the specific aim of targeting different cell pathways and immune-checkpoints that have been recognized to drive tumour progression. The following attempts to provide a review of literature focusing on the available data concerning novel treatments and future prospective for the management of metastatic STSs.

Badalamenti G., Messina C., De Luca I., Musso E., Casarin A., Incorvaia L. (2019). Soft tissue sarcomas in the precision medicine era: new advances in clinical practice and future perspectives. LA RADIOLOGIA MEDICA, 124(4), 259-265 [10.1007/s11547-018-0883-6].

Soft tissue sarcomas in the precision medicine era: new advances in clinical practice and future perspectives

Badalamenti G.
;
De Luca I.;Musso E.;Casarin A.;Incorvaia L.
2019-01-01

Abstract

Soft tissue sarcomas (STSs) represent a rare and heterogeneous group of solid tumours derived from mesenchymal progenitors and account for 1% of all adult malignancies. Although in the last decade anthracycline-based chemotherapy single agent or in combinations has been able to improve clinical benefits, prognosis is still poor and STSs represent an important unmet medical need. Continuous advances in cancer genetics and genomics have contributed to change management paradigms of STSs as it occurred for other solid tumours. Several treatments have been recently developed with the specific aim of targeting different cell pathways and immune-checkpoints that have been recognized to drive tumour progression. The following attempts to provide a review of literature focusing on the available data concerning novel treatments and future prospective for the management of metastatic STSs.
Badalamenti G., Messina C., De Luca I., Musso E., Casarin A., Incorvaia L. (2019). Soft tissue sarcomas in the precision medicine era: new advances in clinical practice and future perspectives. LA RADIOLOGIA MEDICA, 124(4), 259-265 [10.1007/s11547-018-0883-6].
File in questo prodotto:
File Dimensione Formato  
Radologia Medica.pdf

accesso aperto

Tipologia: Pre-print
Dimensione 712.87 kB
Formato Adobe PDF
712.87 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/407155
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 9
social impact